To summarize, 18FDG PET/CT is extremely useful in the evalution of patients with suspected relapse of colorectal cancer, especially in cases with elevated carcinoembryonic antigen (CEA) and negative, equivocal or non-specific findings on conventional imaging techniques, and to characterize post-therapy presacral masses. This evidence concerns the gene CEACAM5 and colorectal cancer.